{
  "id": "asdas_esr",
  "title": "Ankylosing Spondylitis Disease Activity Score with ESR (ASDAS-ESR)",
  "description": "Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically ESR. The ASDAS-ESR is a composite index to assess disease activity in axial spondyloarthritis, combining patient-reported outcomes with laboratory measures to provide a comprehensive evaluation of disease activity.",
  "category": "rheumatology",
  "version": "2009",
  "parameters": [
    {
      "name": "back_pain",
      "type": "integer",
      "required": true,
      "description": "Overall level of AS neck, back, or hip pain (0-10 scale)",
      "validation": {
        "min": 0,
        "max": 10
      },
      "unit": "points"
    },
    {
      "name": "morning_stiffness",
      "type": "integer",
      "required": true,
      "description": "Overall level of morning stiffness from the time you wake up (0-10 scale)",
      "validation": {
        "min": 0,
        "max": 10
      },
      "unit": "points"
    },
    {
      "name": "patient_global",
      "type": "integer",
      "required": true,
      "description": "How active was your spondylitis, on average, during the last week (0-10 scale)",
      "validation": {
        "min": 0,
        "max": 10
      },
      "unit": "points"
    },
    {
      "name": "peripheral_pain",
      "type": "integer",
      "required": true,
      "description": "Overall level of pain/swelling in joints other than neck, back, or hips (0-10 scale)",
      "validation": {
        "min": 0,
        "max": 10
      },
      "unit": "points"
    },
    {
      "name": "esr",
      "type": "integer",
      "required": true,
      "description": "Erythrocyte Sedimentation Rate",
      "validation": {
        "min": 0,
        "max": 200
      },
      "unit": "mm/hr"
    }
  ],
  "result": {
    "name": "asdas_esr_score",
    "type": "float",
    "unit": "points",
    "description": "ASDAS-ESR score calculated from clinical and laboratory parameters"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 1.3,
        "stage": "Inactive",
        "description": "Inactive disease",
        "interpretation": "Disease activity is inactive. Patient has minimal symptoms and inflammation markers are low. Continue current management and monitor regularly."
      },
      {
        "min": 1.3,
        "max": 2.1,
        "stage": "Moderate",
        "description": "Moderate disease activity",
        "interpretation": "Disease activity is moderate. Consider optimization of current therapy or initiation of biological therapy if not already on treatment. Monitor closely for response."
      },
      {
        "min": 2.1,
        "max": 3.5,
        "stage": "High",
        "description": "High disease activity",
        "interpretation": "Disease activity is high. Strongly consider biological therapy if not already initiated. Increase monitoring frequency and assess treatment response regularly."
      },
      {
        "min": 3.5,
        "max": 10,
        "stage": "Very High",
        "description": "Very high disease activity",
        "interpretation": "Disease activity is very high. Urgent consideration for biological therapy or switching to alternative biological agent if already on treatment. Close monitoring and rapid treatment optimization required."
      }
    ]
  },
  "references": [
    "Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009 Jan;68(1):18-24. doi: 10.1136/ard.2008.094870.",
    "van der Heijde D, Lie E, Kvien TK, Sieper J, van den Bosch F, Listing J, Braun J, Landewé R. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826.",
    "Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011 Jan;70(1):47-53. doi: 10.1136/ard.2010.138594."
  ],
  "formula": "ASDAS-ESR = 0.08 × Back Pain + 0.07 × Duration of Morning Stiffness + 0.11 × Patient Global + 0.09 × Peripheral Pain/Swelling + 0.29 × √(ESR)",
  "notes": [
    "All patient-reported parameters (back pain, morning stiffness, patient global, peripheral pain) are assessed on a 0-10 numerical rating scale or visual analogue scale.",
    "ESR should be measured in mm/hr using standard laboratory methods.",
    "The ASDAS-CRP version (using C-reactive protein) is preferred over ASDAS-ESR when CRP is available.",
    "Cut-offs for improvement: ≥1.1 units indicates clinically important improvement, ≥2.0 units indicates major improvement.",
    "This score is validated for axial spondyloarthritis (including ankylosing spondylitis) patients."
  ]
}